Data demonstrate sustained peritoneal disease control and reinforce the potential of Oncoinvent's novel radiopharmaceutical therapy to target peritoneal disease in colorectal cancer OSLO, Norway, June 18, 2025 /PRNewswire/ -- Oncoinvent ASA, a clinical-stage radiopharmaceutical company...
Hence then, the article about oncoinvent announces positive final data from phase 1 2a trial of radspherin in patients with colorectal peritoneal metastases was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Oncoinvent Announces Positive Final Data from Phase 1/2a Trial of Radspherin® in Patients with Colorectal Peritoneal Metastases )
Also on site :
- Troopers: Car veers off road, hits several trees in Wayland, seriously injuring two Rochester women
- 1971 Classic Rock Hit, Remade 32 Years Later With a Music Video Starring Halle Berry, Was Originally Written for an Abandoned Rock Opera
- ‘Zootopia 3’ Is Officially Happening — and Opening the City to a New Kind of Animal